Biotech

All Articles

Lykos 'remorses' certainly not revealing research study offenses with author

.Psychopharmacology has actually pulled three write-ups concerning midstage professional test inform...

Analysts go into Avidity's DMD win, showing subtleties in information

.Avidity Biosciences impressed financiers along with stage 1/2 information in Duchenne muscular dyst...

Actinogen's cortisol blocker falls short phase 2 depression study

.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a stage 2 research stud...

Bivictrix chooses going personal only method to take ADC right into facility

.Antibody-drug conjugates (ADCs) have gone to the center of several a billion-dollar biobuck licensi...

TPG bests up funds to $580M for expenditures across life sciences

.Asset manager TPG, which has assisted biotechs including Sionna Therapeutics and Santa Ana Biograph...

Merck quits period 3 TIGIT trial in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually suffered one more obstacle. Months after shuttering a pe...

After a challenging year, Exscientia folds up into Recursion

.After a year defined through pipe cuts, the variation of its own chief executive officer as well as...

Cullinan, after $25M deal, restore bispecific to Harbour

.Cullinan Therapy was made an impression on good enough along with Harbour BioMed's bispecific immun...

A more detailed check out Strong Biotech's Ferocious 15

.In this week's incident of "The Top Line," our experts are actually diving in to Brutal Biotech's y...

Lilly faces period 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party celebrating the approval of Alzheimer's...